hrp0094fc9.6 | Growth Hormone and IGFs | ESPE2021
Betzmann Deborah
, Doring Michaela
, Blumenstock Gunnar
, Erdmann Friederike
, Grabow Desiree
, Lang Peter
, Binder Gerhard
,
Background: Hematopoietic stem cell transplantation (HSCT) is associated with severe medical complications and variable outcome depending on the recipients disease stage and health condition. As serum-IGF 1 is decreased in patients with severe illness, after major surgery, in malnutrition, and other conditions that cause catabolic metabolism, it may serve as predictive biomarker for transplant outcome.Individuals and Methods: Based...